权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

RNA Processing in Cancer Conference: From Bench to Bedside

癌症会议中的 RNA 处理：从实验室到临床

基本信息

批准号：
10752111
负责人：
OLGA ANCZUKOW-CAMARDA
金额：
$ 1.09万
依托单位：
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10752111
关键词：
Acceleration Alternative Splicing Area Biology Cancer Biology Career Mobility Cell physiology Clinical Collaborations Creativeness Defect Development Discipline Education Event Fostering Future Goals Immune response Immune system Industry Intention Knowledge Learning Malignant Neoplasms Modification Molecular Oncology Outcome Pathogenesis Pharmaceutical Preparations Pharmacologic Substance Physical condensation Physicians Postdoctoral Fellow Process RNA RNA Processing RNA Splicing RNA-targeting therapy Research Research Personnel Resources Role Schedule Scholarship Science Scientist Series Site Therapeutic Translations Underrepresented Minority Woman anticancer research bench to bedside cancer clinical trial cancer initiation career career development collaborative environment drug development graduate student high throughput technology interest lectures meetings next generation novel novel strategies novel therapeutic intervention posters pre-doctoral preclinical trial programs recruit response social symposium targeted cancer therapy therapeutic target tumorigenesis

项目摘要

SUMMARY Alterations in RNA processing have recently emerged as a new cancer hallmark and a promising target for cancer therapies. The fields of cancer and RNA biology have traditionally been studied in isolation; however, an integrated approach between these fields is needed to prepare the next generation of scientists and physicians to uncover the mechanisms of their relationship. Currently, no conference in the cancer field incorporates RNA biology. To fill this gap, we propose the unique and timely interdisciplinary conference “FASEB RNA processing in cancer: from bench to bedside” to foster future collaborations and research advances. The main objectives of this meeting are to define the role of RNA processing in cancer initiation, progression, and drug responses, and to identify novel therapeutic strategies to target RNA processing defects in cancer. This 5-day long conference to be held in Houston, TX in November 2023 will bring together scientists, including graduate students, postdoctoral fellows, and junior and senior investigators, as well as clinicians and physicians, and scientists from industry and pharmaceutical companies, from the fields of RNA biology and cancer. While putting together the speakers list, the organizing committee made a commitment to increased diversity. The conference program will include invited lectures, short talks from trainees, and educational/professional sessions, featuring leading scientists with distinct expertise yet shared interest in understanding the role of RNA processing in cancer pathogenesis and developing novel cancer therapeutics. Our specific aims are to (1) Organize an interdisciplinary conference on RNA processing and cancer; (2) Promote interactions to foster collaborative research and career advancement; (3) Foster the recruitment and development of diverse junior investigators in RNA biology and cancer research fields; (4) Accelerate translation of fundamental advances into novel clinical cancer therapeutics. The proposed conference will cross-pollinate the fields of RNA biology and cancer biology, seed new collaborations across disciplines, and facilitate the next generation of scientists to implement novel strategies towards targeting RNA processing in oncology.

总结